Jessica McBroom

March 18, 2022

Jessica McBroom is Director for International Economics and Competitiveness at the National Security Council, White House. Jessica has driven the President’s supply chain agenda since the beginning of the Biden-Harris Administration, including as the chief coordinator for the implementation of Executive Order 14017 on America’s Supply Chains. She is currently on detail from the Office of Industrial Policy at the Department of Defense. Prior to that, Jessica was in the private sector as Vice President at a major U.S. financial institution and also served as a Director at a major manufacturing-focused trade association. Jessica has also held positions at the Department of State. She has a B.A. from Tulane University in political science and a minor in the French language. She is originally from Detroit, Michigan

Andrei Iancu – Congressional Testimony: Hearing on the Patent Eligibility Restoration Act (PERA)

October 13, 2025

On October 8th, 2025, Andrei Iancu testified before the Senate Judiciary Committee, Subcommittee on Intellectual Property during the Hearing on the Patent Eligibility Restoration Act (PERA). Iancu, Partner at Sullivan & Cromwell, former Under Secretary of Commerce for IP and Director of the U.S. Patent and Trademark Office (USPTO), and

How Europe Lost Global Biopharmaceutical R&D Leadership to the United States: Lessons for Today

September 9, 2025

By Anne Prichett Today, the United States leads the world in biopharmaceutical industry research and development (R&D), supporting nearly five million jobs and generating more than $1.65 trillion in economic output. This position of global leadership, however, is relatively recent. Until the late 1980s, Europe–particularly Germany, France,

If Private Sector R&D Is the Future, IP Policy Must Catch Up

September 8, 2025

By Chris Borges The President’s Budget Request for fiscal year 2026 (FY 2026) includes steep cuts to federal research and development (R&D) funding—a troubling signal for U.S. innovation and economic security. While congressional committees may push back on the most severe reductions, the signs are clear: Federal R&D funding is likely